Continuous Transdermal Nitroglycerin No Aid for Hot Flashes
FRIDAY, June 9, 2023 (HealthDay News) -- Uninterrupted transdermal nitroglycerin (NTG) therapy does not offer sustained benefit for hot flashes, according to a study published online June 5 in JAMA Internal Medicine.
Alison J. Huang, M.D., from the University of California in San Francisco, and colleagues randomly assigned 141 perimenopausal and postmenopausal women who experienced at least seven hot flashes per day to either uninterrupted daily use of transdermal NTG (participant-directed dose titration from 0.2 to 0.6 mg/hour) or identical placebo patches.
The researchers found that over five weeks, the estimated change in any hot flash frequency associated with NTG was −0.9 (95 percent confidence interval [CI], −2.1 to 0.3) episodes per day versus placebo, while change in moderate-to-severe hot flash frequency was −1.1 (95 percent CI, −2.2 to 0) episodes per day. Treatment with NTG did not significantly decrease the frequency of any hot flashes (−0.1 episodes per day; 95 percent CI, −1.2 to 0.4) or moderate-to-severe hot flashes (−0.5 episodes per day; 95 percent CI, −1.6 to 0.7) versus placebo at 12 weeks. Two-thirds of NTG users (67.1 percent) and 5.6 percent of placebo participants reported headache, which decreased to one participant in each group at 12 weeks.
"The findings of this trial do not support daily uninterrupted use of transdermal NTG as a nonhormonal treatment for menopause-associated vasomotor symptoms," the authors write.
Related Posts
Certain Meds Not Cost-Effective for First-Line Therapy of T2DM
MONDAY, Oct. 3, 2022 (HealthDay News) -- Sodium-glucose cotransporter-2 (SGTL2)...
CPAP ayuda a reducir los riesgos cardíacos – pero hay que usarlo
JUEVES, 5 de octubre de 2023 (HealthDay News) -- Para quienes padecen de apnea...
Fatal Drug Overdoses Quadrupled From 1999 to 2020
TUESDAY, Sept. 19, 2023 (HealthDay News) -- Drug overdose deaths increased...
Head-to-Head Study Finds Which Diabetes Meds Are Best for the Heart
TUESDAY, May 9, 2023 (HealthDay News) -- There are many medications for type 2...